India News | Written by Purva Chitnis | Wednesday July 15, 2020
Maharashtra continues to face acute shortage of two key medicines being used to treat coronavirus in India - Remdesivir and Tocilizumab injections, both approved by the US FDA for the treatment of COVID-19. With this, relatives of patients getting treatment in private hospitals of Mumbai, Thane and Pune have been left to fend for themselves. Expert...
www.ndtv.com